UK_Head of Market Access & Business Intelligence

##  of Market Access & Business Intelligence応募locations:
England time type:
Full time posted on:
募集開始 - 今日time left to apply:
終了日: 2026年8月28日 (応募可能な残り時間: 30 日以上)job requisition :
JR-Celltrion Group provides biosimilar and innovative biopharmaceutical medications to help increase patient access to advanced therapies around the world.
Celltrion Group offers biologics to about 110 countries, along with more than 30 global partners around the world. With hands-on experience and knowledge accumulated through years of working in the advanced pharmaceutical markets around the world, Celltrion Group has been securing distribution channels and providing patients with biosimilars at affordable prices.
** Overall Purpose of the Role****:
** The Head of Market Access & Business Intelligence is accountable for the UK market access strategy and execution across Celltrion’s biosimilar portfolio. This role leads all market access activities (national and regional), ensuring optimal patient access and sustainable commercial outcomes through effective engagement with NHS England and commissioning bodies, procurement hubs and trusts, and health policy stakeholders. The post-holder provides leadership and insight across tendering, pricing governance, HTA/NICE guidance, and payer/customer strategy, underpinned by robust business intelligence and compliant stakeholder engagement.
** Accountability:**
* ** Market Access Strategy & Delivery**:
Develop, own and deliver the annual UK Market Access strategy and operating plan for the biosimilars portfolio, aligned to corporate objectives, NHS priorities and the evolving policy environment.
* ** Access Planning & Stakeholder Engagement:
** Lead national and regional access planning, including stakeholder mapping, segmentation and engagement plans for NHS procurement bodies across England and the devolved nations, Integrated Care Boards (ICBs), health boards, provider trusts, procurement hubs and key influencers.
* ** Policy Influence & External Engagement:
** Monitor, interpret and help shape the UK policy and reimbursement environment through engagement with the Department of Health and Social Care (DHSC), NHS England and relevant stakeholders; represent the organisation in key industry forums including the British Biosimilars Association (BBA), Medicines UK and ABPI working groups, and coordinate engagement with MHRA on biosimilar-specific considerations in partnership with the Responsible Person/QA & Regulatory Affairs teams.
* ** Competitor Intelligence & Strategic Foresight**:
Lead systematic competitor intelligence on price positioning and forward-looking policy landscaping, including analysis of Voluntary Scheme for Branded Medicines Pricing and Access (VPAG) and related frameworks, to anticipate market shifts, identify risks and opportunities, and enable proactive, strategically agile decision-making.
* ** NHS Partnerships & Access Enablement**:
Build and maintain strategic partnerships with NHS procurement and commissioning stakeholders (including NHS England and CMU/procurement leads), leading biosimilar-specific access initiatives such as switching frameworks, pathway optimisation, and service redesign and implementation resources in collaboration with Medical and system partners.
* ** Tendering, Contracting & Pricing Governance**:
Be accountable for tender and contracting outcomes across the UK (NHS and, where applicable, private markets), including ownership of tender pipeline governance, bid/no-bid decisions, pricing governance, scenario planning and senior escalation management, to deliver sustainable revenue, margin and access.
* ** Commercial Integration & Field Enablement**:
Provide market access leadership to commercial account teams (RBMs/KAMs), ensuring consistent, compliant and up-to-date value messaging to support biosimilar adoption and switching programmes.
* ** Cross-functional Alignment & Execution****:
** Partner cross-functionally with Medical, Regulatory Affairs/QA (Responsible Person), Marketing, Supply/Operations and Finance to ensure access strategy, evidence generation and supply plans are aligned and executable.
* ** Performance Management & Insight…